NEWLY DIAGNOSED SUPRATENTORIAL IDH WILD-TYPE GLIOBLASTOMA

Clinical trials for NEWLY DIAGNOSED SUPRATENTORIAL IDH WILD-TYPE GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new NEWLY DIAGNOSED SUPRATENTORIAL IDH WILD-TYPE GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for NEWLY DIAGNOSED SUPRATENTORIAL IDH WILD-TYPE GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Light therapy for brain cancer shows promise but trial halted early

Disease control Terminated

This study tested a new approach for glioblastoma, an aggressive brain cancer. Doctors injected a light-sensitive drug into the tumor and then activated it with a special laser. The goal was to see if it was safe and could help control the cancer. The trial was stopped early afte…

Matched conditions: NEWLY DIAGNOSED SUPRATENTORIAL IDH WILD-TYPE GLIOBLASTOMA

Phase: PHASE2 • Sponsor: photonamic GmbH & Co. KG • Aim: Disease control

Last updated Jun 15, 2026 19:07 UTC

NEWLY DIAGNOSED SUPRATENTORIAL IDH WILD-TYPE GLIOBLASTOMA

Get alerted when new NEWLY DIAGNOSED SUPRATENTORIAL IDH WILD-TYPE GLIOBLASTOMA trials appear

Light therapy for brain cancer shows promise but trial halted early